Search

Author/Creator Lee, SD

1. OC-005 A Multicenter, Double-Blind, Placebo (PBO)-Controlled Ph3 Study of Ustekinumab (UST), A Human IL-12/23P40 MAB, in Moderate-Severe Crohn's Disease (CD) Refractory to anti-TNFΑ: UNITI-1. (17th August 2016)

Authors:
Rutgeerts, P; Gasink, C; Blank, M; Lang, Y; Johanns, J; Gao, L-L; Sands, B; Hanauer, S; Feagan, B; Targan, S; Ghosh, S; de Villiers, W; Colombel, J-F; Lee, SD; Desreumaux, P; Loftus, EV; Vermeire, S; Sandborn, WJ
Journal:
Gut
Issue:
Volume 65(2016)Supplement 1
Page Start:
A3
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. OC-057 A PH3 Randomised, Multicenter, Double-Blind, Placebo (PBO)-Controlled Study of Ustekinumab (UST) Maintenance Therapy in Moderate–Severe Crohn's Disease (CD) PTS: Results from IM-UNITI. (17th August 2016)

Authors:
Sandborn, WJ; Feagan, BG; Gasink, C; Jacobstein, D; Gao, L-L; Johanns, J; Sands, B; Hanauer, S; Targan, S; Ghosh, S; de Villiers, W; Colombel, J-F; Lee, SD; Dieleman, L; Katz, S; Rutgeerts, P
Journal:
Gut
Issue:
Volume 65(2016)Supplement 1
Page Start:
A32
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗